Nuvo Pharmaceuticals Inc NRIFF

RE:RE:Initial Comments on Arrangement

[Lazaros]

It is hard for me to determine the full meaning of the documents filed without know the actual terms for the plan of arrangement. We, collectively, need to know how many shares each company will have, how the cash will be split, the division of the intangibles on the balance sheet, etc. 

My hope would be that Crescita will start from a smaller outstanding share base (hopefully supporting a higher share price), knowing full well that there will be dilution down the road. Hopefully devco has a small share base as well, to support a larger EPS figure, hence share price. With currency as a tailwind, and Horizon delivering the sales, there is a window of opportunity to deliver really meaningful shareholder value, moreso if fundamentals are back in favour next year.

I am very interested to see how they plan to implement this division of companies.